Simultaneous radiochemotherapy versus concomitant boost radiation for advanced inoperable head and neck cancer

Acta Oncologica

Volumn 39, Issue 4, 2000, Pages 523-528

  Schäfer, Ulrich ^a   Schüller, Patrick ^a   Micke, Oliver ^a   Willich, Normann ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HEMORRHAGIC CYSTITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; SKIN TOXICITY; SURVIVAL TIME; XEROSTOMIA;

EID: 0033804564     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013456     Document Type: Article

References (17)

1. A rafidomized trial of accelerated versus conventional radiotherapy in head and neck cancer
2. Accelerated fractionation (AF) compared to conventional fractionation (CF) improved head and neck cancers: Results of the EORTC 22851 randomized trial
3. Benefits of accelerated hyperfractionation for head and neck cancer
4. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
5. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
6. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
7. An overview of randomized trials of adjuvant chemotherapy in head and neck cancer
8. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer
9. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
10. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
11. Reporting results of cancer treatment
12. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa
13. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer
14. 2/d) in locally advanced head and neck cancer
15. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
16. Base-of-tongue carcinoma: Treatment results using concomitant boost radiotherapy
17. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials